Crispr Therapeutics shares tumble after significant earnings miss
Investing.com - Zumiez reported on Thursday second quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Zumiez announced earnings per share of $0.16 on revenue of $220M. Analysts polled by Investing.com EPS of $0.4725 on revenue of $232.71M.
Zumiez 's are down 16.15% and is trading at $26.54 , still down 51.83% from its 52 week high of $55.10 set on Monday, November 22, 2021.
Zumiez follows other major Consumer Discretionary sector earnings this month
Zumiez's report follows an earnings beat by Home Depot on Tuesday, August 16, 2022, who reported EPS of $5.05 on revenue of $43.79B, EPS of $4.95 on revenue of $43.36B.
Lowe’s had beat expectations on Wednesday, August 17, 2022 with second quarter EPS of $4.67 on revenue of $27.48B, for EPS of $4.58 on revenue of $28.12B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar